Safety of LDL-C Reduction – How Low is Optimal?

Safety of LDL-C Reduction – How Low is Optimal?

Even when using intensive statin monotherapy, many patients fail to achiev…

Expiration Date: 9/15/2017

Max Credits: 0

View Activity

Patients with a History of Peripheral Artery Disease

Patients with a History of Peripheral Artery Disease

This CME activity will review risk stratification and treatment for the se…

Expiration Date: 1/11/2019

Max Credits: 0

View Activity

Antiplatelet Agents for Secondary Prevention of Cardiovascular Events in Patients with a History of Cerebrovascular Disease

Antiplatelet Agents for Secondary Prevention of Cardiovascular Events in Patients with a History of Cerebrovascular Disease

In this CME activity, the role of antiplatelet therapy for the secondary p…

Expiration Date: 1/11/2019

Max Credits: 0

View Activity

Antiplatelet Agents for Secondary Prevention of Thrombotic Cardiovascular Events in Patients With a History of Myocardial Infarction

Antiplatelet Agents for Secondary Prevention of Thrombotic Cardiovascular Events in Patients With a History of Myocardial Infarction

This CME activity provides clinical trial data and concise guidance for th…

Expiration Date: 1/30/2018

Max Credits: 0

View Activity

Patient Identification

Patient Identification

Dr. Bonaca evaluates the mechanisms, benefits, and risks of current antipl…

Expiration Date: 2/23/2017

Max Credits: 0

View Activity

Anti-platelet Therapy

Anti-platelet Therapy

Dr. Mahaffey reviews the historical use of antiplatelet therapy in patient…

Expiration Date: 1/11/2019

Max Credits: 0

View Activity

High-risk Patient

High-risk Patient

Dr. Steg examines the burden and independent predictors of cardiovascular …

Expiration Date: 1/11/2019

Max Credits: 0

View Activity

Risk Reduction in Patients with Complex Dyslipidemia

Risk Reduction in Patients with Complex Dyslipidemia

Dr. Brown discusses incorporating therapeutic regimens that may reduce res…

Expiration Date: 2/23/2017

Max Credits: 0

View Activity

IMPROVE-IT: Ezetimibe Added to Statin Therapy After Acute Coronary Syndromes – A Critical Appraisal

IMPROVE-IT: Ezetimibe Added to Statin Therapy After Acute Coronary Syndromes – A Critical Appraisal

Dr. Cannon assesses the impact of the IMPROVE-IT clinical trial and how it…

Expiration Date: 1/11/2019

Max Credits: 0

View Activity

Progress Toward a Consensus on Cardiovascular Risk Reduction

Progress Toward a Consensus on Cardiovascular Risk Reduction

Dr. Wright assesses the impact of LDL-C reduction in patients with complex…

Expiration Date: 2/23/2017

Max Credits: 0

View Activity